HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Long-Term Deferred Tax (2015 - 2025)

HUTCHMED (China)'s (HMDCF) quarterly Long-Term Deferred Tax came in at $12.7 million in Q4 2025, down 9.43% quarter-over-quarter from $14.0 million in Q4 2023.

Analysis

HUTCHMED (China) (HMDCF) Long-Term Deferred Tax (2015 - 2025) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Long-Term Deferred Tax for 10 consecutive years, with $12.7 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $12.7 million in Q4 2025; TTM through Dec 2025 was $12.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $12.7 million, changed N/A from the prior year.
  • Long-Term Deferred Tax was $12.7 million for Q4 2025 at HUTCHMED (China), down from $14.0 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $14.0 million in Q4 2023 and troughed at $6.6 million in Q4 2021.
  • A 4-year average of $11.5 million and a median of $12.7 million in 2022 frame the typical range for Long-Term Deferred Tax.
  • Across the five-year window, Long-Term Deferred Tax jumped 338.02% in 2021 and increased 10.4% in 2023, its largest moves.
  • Over 4 years, Long-Term Deferred Tax stood at $6.6 million in 2021, then jumped by 90.72% to $12.7 million in 2022, then increased by 10.4% to $14.0 million in 2023, then declined by 9.43% to $12.7 million in 2025.
  • The last three Long-Term Deferred Tax figures came in at $12.7 million (Q4 2025), $14.0 million (Q4 2023), and $12.7 million (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 12.66 Mn
Dec 31, 2023 13.97 Mn
Dec 31, 2022 12.66 Mn
Dec 31, 2021 6.64 Mn
Dec 31, 2020 1.52 Mn
Jun 30, 2020 -2.39 Mn
Dec 31, 2019 815,000.00
Dec 31, 2018 580,000.00
Jun 30, 2018 681,000.00
Dec 31, 2017 633,000.00
Dec 31, 2016 372,000.00
Jun 30, 2016 215,000.00
Dec 31, 2015 250,000.00